After stalling for some time, negotiations for an economic partnership agreement (EPA) between the European Union (EU) on the one hand and the Southern African Customs Union (SACU), Mozambique and Angola on the other have recently restarted. According to an article published in Business Day on 10 February 2011, Xavier Carim - Deputy Director-General for international trade at the Department of Trade and Industry - is reported to have indicated that the EPA "should strike a balance between the levels of market access, regional harmonisation of rules, customs co-operation and safety, enforcement of intellectual property laws, competition, investment and procurement."
Today, 14 March 2011, The Treatment Action Campaign (TAC) and its General Secretary, Vuyiseka Dubula, will be honoured by Shared Interest at a gala event in New York.
The Treatment Action Campaign (TAC), SECTION27 and Médecins Sans Frontières / Doctors Without Borders (MSF) South Africa voice support for their partners across the world opposing provisions in a proposed free trade agreement (FTA) between India and the European Union (EU) that threaten the sustainable supply of affordable medicines to millions of people in the developing world.
AIDS campaigners have welcomed the British Government's backing for the Global Fund to fight AIDS, TB and Malaria which has saved more than six and a half million lives since its creation in 2002.
The announcement came as part of the Government's Multilateral Aid Review (MAR), delivered in the House of Commons yesterday by Secretary of State for International Development, Andrew Mitchell.
On 12 November 2010, TAC and partners jointly sent open letters to Cepheid and Tibotec calling for affordable and expanded access to the Xpert® MTB/RIF TB diagnostic test that works on the GeneXpert® diagnostic system and for expanded access to the drug TMC207.
The Xpert MTB/RIF is a TB diagnostic test that detects TB disease and rifampicin resistance within two hours and is much more accurate than the currently available tests at district health centres. TMC207 is an experimental drug for TB that has shown success in patients with drug resistant TB. The addition of TMC207 to standard therapy resulted in a quicker time to sputum-negative conversion for patients with drug resistant TB in a phase II clinical trial.
Attached is an overview of the responses received from Cepheid and Tibotec, as well as, developments in pricing and endorsements.
TAC reports on our resources for health campaign, the state of healthcare and our interventions at a district level during September through November 2010.
Resources for Health Campaign
Fund the fund
Financial Transaction Tax
Monitoring budgets and expenditure
Integrated Support Team Reports
State of healthcare in the districts
Implementation of new guidelines – challenges and successes
Report from Gert Sibande
Interventions at a district level
Gender based violence
AWARD-WINNING HORSE RIDING INSTRUCTOR LIVING WITH HIV WINS 12 MONTHS’ COMPENSATION
DISMISSAL DECLARED “AUTOMATICALLY UNFAIR”
Treatment Action Campaign (TAC) welcomes the judgment handed down by Judge Bhoola yesterday in the Labour Court in the case of Gary Shane Allpass v Mooikloof Estates (Pty) Ltd.
The Treatment Action Campaign (TAC), The Yezingane Network (YN), Equal Education and SECTION27 welcome the Department of Health’s plans to extend HIV Counselling and Testing (HCT) campaign to children 12 years and older. But we call for it to be done in a measured, phased manner after thorough and consultative planning.
BASED IN CAPE TOWN
RESPONSIBILITIES: (AMONG OTHERS)
On 2 February 2011, the Advertising Standards Committee of the Advertising Standards Authority of South Africa (ASASA) issued a ruling in the very long-running complaint against Christ Embassy lodged by the Treatment Action Campaign (TAC) in November 2009.